Results 31 to 40 of about 1,874,188 (207)

Effectiveness of one dose of oral cholera vaccine in response to an outbreak: a case-cohort study

The Lancet Global Health, 2016
Background: Oral cholera vaccines represent a new effective tool to fight cholera and are licensed as two-dose regimens with 2–4 weeks between doses.
Dr. Andrew S Azman, PhD, Lucy A Parker, PhD, John Rumunu, MPH, Fisseha Tadesse, MPH, Francesco Grandesso, MPH, Lul L Deng, MD, Richard Laku Lino, MPH, Bior K Bior, PhD, Michael Lasuba, MS, Anne-Laure Page, PhD, Lameck Ontweka, BS, Augusto E Llosa, PhD, Sandra Cohuet, MD, Lorenzo Pezzoli, PhD, Dossou Vincent Sodjinou, MD, Abdinasir Abubakar, MD, Amanda K Debes, PhD, Allan M Mpairwe, MPH, Joseph F Wamala, MPH, Christine Jamet, MPH, Justin Lessler, PhD, Prof. David A Sack, MD, Marie-Laure Quilici, PhD, Iza Ciglenecki, MD, Francisco J Luquero, PhD   +24 more
doaj   +1 more source

Type II NKT Cell Agonist, Sulfatide, Is an Effective Adjuvant for Oral Heat-Killed Cholera Vaccines

Vaccines, 2021
Oral vaccination has the potential to offer a safer and more efficacious approach for protection against enteric pathogens than injection-based approaches, especially in developing countries. One key advantage is the potential to induce intestinal immune
Aqel Albutti, Stephanie Longet, Craig P. McEntee, Shauna Quinn, Alex Liddicoat, Cristiana Rîmniceanu, Nils Lycke, Lydia Lynch, Susanna Cardell, Ed C. Lavelle   +9 more
doaj   +1 more source

A randomized, placebo-controlled trial of the bivalent killed, whole-cell, oral cholera vaccine in adults and children in a cholera endemic area in Kolkata, India. [PDF]

PLoS ONE, 2008
An effective vaccine against cholera has been used for public health purposes in Vietnam since the 1990s. This vaccine was reformulated to meet WHO requirements.
Dilip Mahalanabis, Anna Lena Lopez, Dipika Sur, Jacqueline Deen, Byomkesh Manna, Suman Kanungo, Lorenz von Seidlein, Rodney Carbis, Seung Hyun Han, Seong Hye Shin, Stephen Attridge, Raman Rao, Jan Holmgren, John Clemens, Sujit K Bhattacharya   +14 more
doaj   +1 more source

Oral cholera vaccine use in Zanzibar: socioeconomic and behavioural features affecting demand and acceptance

BMC Public Health, 2009
Background Cholera remains a serious public health problem in low-income countries despite efforts in the past to promote oral rehydration therapy as major treatment.
Chaignat Claire-Lise, Weiss Mitchell G, Pach Al, Ali Said M, Hutubessy Raymond, Schaetti Christian, Khatib Ahmed M   +6 more
doaj   +1 more source

Vaccines for cholera control: does herd immunity play a role. [PDF]

, 2007
The author discusses a new study that mathematically simulated different vaccine coverage levels in the Matlab region of Bangladesh using a historic vaccine trial ...
Lorenz von Seidlein, von Seidlein Lorenz, von Seidlein, Lorenz   +2 more
core   +2 more sources

Prolonging herd immunity to cholera via vaccination: Accounting for human mobility and waning vaccine effects.

PLoS Neglected Tropical Diseases, 2018
BackgroundOral cholera vaccination is an approach to preventing outbreaks in at-risk settings and controlling cholera in endemic settings. However, vaccine-derived herd immunity may be short-lived due to interactions between human mobility and imperfect ...
Corey M Peak, Amanda L Reilly, Andrew S Azman, Caroline O Buckee   +3 more
doaj   +1 more source

Evaluation and use of surveillance system data toward the identification of high-risk areas for potential cholera vaccination: a case study from Niger. [PDF]

, 2012
In 2008, Africa accounted for 94% of the cholera cases reported worldwide. Although the World Health Organization currently recommends the oral cholera vaccine in endemic areas for high-risk populations, its use in Sub-Saharan Africa has been limited ...
Grais, R, Mayana, B, Llosa, A E, Llosa Augusto E, Jose Guerra, Rebecca F Grais, Djibo Ali, Manzo Mahamane L, Manzo, M L, Mahamane L Manzo, Bachir Mayana, Djibo, A, Mayana Bachir, Augusto E Llosa, Ali Djibo, Guerra, J, Guerra Jose, Grais Rebecca F   +17 more
core   +1 more source

Controlling Endemic Cholera with Oral Vaccines

PLoS Medicine, 2007
على الرغم من أن التقدم في علاج الإماهة جعل الكوليرا مرضًا يمكن علاجه مع انخفاض معدل الوفيات في الحالات في البيئات التي توفر الرعاية الطبية المناسبة، إلا أن الكوليرا لا تزال تفرض وفيات كبيرة في أكثر سكان العالم فقرًا. تتوفر لقاحات الكوليرا الفموية المعتمدة على الخلايا الكاملة والمرخصة دوليًا (OCVs) منذ أكثر من عقد من الزمان، ولكن لم يتم استخدامها ...
Ira M. Longini, Azhar Nizam, Mohammad Ali, Muhammad Yunus, Neeta Shenvi, John D. Clemens   +5 more
openaire   +4 more sources

Organization and implementation of an oral cholera vaccination campaign in an endemic urban setting in Dhaka, Bangladesh

Global Health Action, 2019
Bangladesh has historically been cholera endemic, with seasonal cholera outbreaks occurring each year. In collaboration with the government of Bangladesh, the Infectious Diseases Division, International Centre for Diarrhoeal Disease Research, Bangladesh (
Iqbal Ansary Khan, Ashraful Islam Khan, Anisur Rahman, Shah Alam Siddique, Md. Taufiqul Islam, Md. Amirul Islam Bhuiyan, Atique Iqbal Chowdhury, Nirod Chandra Saha, Prasanta Kumar Biswas, Amit Saha, Fahima Chowdhury, John D. Clemens, Firdausi Qadri   +12 more
doaj   +1 more source

Long-term effectiveness of one and two doses of a killed, bivalent, whole-cell oral cholera vaccine in Haiti: an extended case-control study

The Lancet Global Health, 2018
Summary: Background: No study of long-term protection following killed oral cholera vaccination has been done outside of the historically cholera-endemic areas of south Asia, or has examined protection after a single-dose vaccination regimen. To address
Molly F Franke, ScD, Ralph Ternier, MD, J Gregory Jerome, MD, Wilfredo R Matias, MD, Jason B Harris, MD, Louise C Ivers, MD   +5 more
doaj   +1 more source